Digital submission of adverse event reports for investigational new drug applications reflects FDA’s ongoing modernization efforts - FDA Press Releases

FDA is taking steps towards requiring electronic submission of certain safety reports under an investigational new drug (IND) application into the FDA's Adverse Event Reporting System (FAERS).

from FDA Press Releases RSS Feed https://ift.tt/36lhhv9
via IFTTT